Canada markets open in 8 hours 24 minutes

SOPHiA GENETICS SA (SOPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.8000-0.0500 (-1.03%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close4.8500
Open4.8600
Bid4.7600 x 100
Ask4.9200 x 100
Day's Range4.7000 - 4.9000
52 Week Range2.1300 - 7.3700
Volume65,990
Avg. Volume58,012
Market Cap313.447M
Beta (5Y Monthly)1.17
PE Ratio (TTM)N/A
EPS (TTM)-1.2200
Earnings DateMay 07, 2024 - May 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.67
  • PR Newswire

    SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)

    SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Unilabs, one of the largest diagnostic providers in Europe, and the only provider to offer laboratory, imaging and pathology specialties within one group, is live on the SOPHiA DDM™ Platform. Unilabs will use SOPHiA GENETICS' technology to test for HRD-status in solid tumors and provide expedited analysis across its network in Switzerland.

  • PR Newswire

    SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership

    SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced a strategic partnership with Strand Life Sciences, a pioneer in bioinformatics and diagnostics, to deliver innovative solutions that will fuel the use of precision medicine globally. The new collaboration will leverage the industry-leading strengths from both companies to provide access to advanced genomics technologies, cutting-edge bioinformatics service

  • PR Newswire

    Laboratorio Barnafi-Krause is Live on SOPHiA DDM™

    SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Laboratorio Barnafi-Krause is live on the SOPHiA DDM™ Platform. Laboratorio Barnafi-Krause, located in Chile, has implemented SOPHiA GENETICS' technology to help elevate its testing and analysis of blood cancers and diseases, including Leukemia.